Is NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) Halal?
Shariah Screening — 5 Standards
Based on financial data from September 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.6% / 30% | 15.4% / 30% | 3.0% / 30% | 10.5% / 5% | ✗ NOT HALAL |
| DJIM | 0.6% / 33% | 15.4% / 33% | 3.0% / 33% | 10.5% / 5% | ✗ NOT HALAL |
| MSCI | 2.5% / 33% | 60.9% / 33% | 11.7% / 33% | 10.5% / 5% | ✗ NOT HALAL |
| S&P | 0.6% / 33% | 15.4% / 33% | 3.0% / 33% | 10.5% / 5% | ✗ NOT HALAL |
| FTSE | 2.5% / 33% | 60.9% / 33% | 11.7% / 50% | 10.5% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 22.0% | |
| Operating Margin | -59.0% | |
| Net Margin | -58.3% | |
| Return on Equity (ROE) | -146.3% | |
| Return on Assets (ROA) | -63.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$3M |
| Free Cash Flow | -$3M |
| Total Debt | $266,806 |
| Debt-to-Equity | 3.7 |
| Current Ratio | 6.4 |
| Total Assets | $11M |
Price & Trading
| Last Close | $0.76 |
| 50-Day MA | $0.79 |
| 200-Day MA | $0.78 |
| Avg Volume | 274K |
| Beta | 0.7 |
|
52-Week Range
$0.40
| |
About NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company is based in Eden Prairie, Minnesota.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), NEUROONE MEDICAL TECHNOLOGIES Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is NEUROONE MEDICAL TECHNOLOGIES Corp's debt ratio?
NEUROONE MEDICAL TECHNOLOGIES Corp's debt ratio is 0.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 2.5%.
What are NEUROONE MEDICAL TECHNOLOGIES Corp's key financial metrics?
NEUROONE MEDICAL TECHNOLOGIES Corp has a market capitalization of $37M, and revenue of $9M. The company maintains a gross margin of 22.0% and a net margin of -58.3%. Return on equity stands at -146.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.